These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 32045064)

  • 1. MRI-Based Machine Learning for Differentiating Borderline From Malignant Epithelial Ovarian Tumors: A Multicenter Study.
    Li Y; Jian J; Pickhardt PJ; Ma F; Xia W; Li H; Zhang R; Zhao S; Cai S; Zhao X; Zhang J; Zhang G; Jiang J; Zhang Y; Wang K; Lin G; Feng F; Lu J; Deng L; Wu X; Qiang J; Gao X
    J Magn Reson Imaging; 2020 Sep; 52(3):897-904. PubMed ID: 32045064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-Based Multiple Instance Convolutional Neural Network for Increased Accuracy in the Differentiation of Borderline and Malignant Epithelial Ovarian Tumors.
    Jian J; Li Y; Xia W; He Z; Zhang R; Li H; Zhao X; Zhao S; Zhang J; Cai S; Wu X; Gao X; Qiang J
    J Magn Reson Imaging; 2022 Jul; 56(1):173-181. PubMed ID: 34842320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial Ovarian Tumors.
    Ye R; Weng S; Li Y; Yan C; Chen J; Zhu Y; Wen L
    Korean J Radiol; 2021 Jan; 22(1):106-117. PubMed ID: 32932563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors.
    He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J
    J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric-MRI-Based Radiomics Model for Differentiating Primary Central Nervous System Lymphoma From Glioblastoma: Development and Cross-Vendor Validation.
    Xia W; Hu B; Li H; Geng C; Wu Q; Yang L; Yin B; Gao X; Li Y; Geng D
    J Magn Reson Imaging; 2021 Jan; 53(1):242-250. PubMed ID: 32864825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate Cancer Differentiation and Aggressiveness: Assessment With a Radiomic-Based Model vs. PI-RADS v2.
    Chen T; Li M; Gu Y; Zhang Y; Yang S; Wei C; Wu J; Li X; Zhao W; Shen J
    J Magn Reson Imaging; 2019 Mar; 49(3):875-884. PubMed ID: 30230108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Machine Learning-Based Unenhanced Radiomics Approach to Distinguishing Between Benign and Malignant Breast Lesions Using T2-Weighted and Diffusion-Weighted MRI.
    Liu Y; Jia X; Zhao J; Peng Y; Yao X; Hu X; Cui J; Chen H; Chen X; Wu J; Hong N; Wang S; Wang Y
    J Magn Reson Imaging; 2024 Aug; 60(2):600-612. PubMed ID: 37933890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics Based on Multimodal MRI for the Differential Diagnosis of Benign and Malignant Breast Lesions.
    Zhang Q; Peng Y; Liu W; Bai J; Zheng J; Yang X; Zhou L
    J Magn Reson Imaging; 2020 Aug; 52(2):596-607. PubMed ID: 32061014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiating Benign from Malignant Renal Tumors Using T2- and Diffusion-Weighted Images: A Comparison of Deep Learning and Radiomics Models Versus Assessment from Radiologists.
    Xu Q; Zhu Q; Liu H; Chang L; Duan S; Dou W; Li S; Ye J
    J Magn Reson Imaging; 2022 Apr; 55(4):1251-1259. PubMed ID: 34462986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasts Between Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MR in Diagnosing Malignancies of Breast Nonmass Enhancement Lesions Based on Morphologic Assessment.
    Li Y; Chen J; Yang Z; Fan C; Qin Y; Tang C; Yin T; Ai T; Xia L
    J Magn Reson Imaging; 2023 Sep; 58(3):963-974. PubMed ID: 36738118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression.
    Li HM; Zhao SH; Qiang JW; Zhang GF; Feng F; Ma FH; Li YA; Gu WY
    J Magn Reson Imaging; 2017 Nov; 46(5):1499-1506. PubMed ID: 28295854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of High-Risk Cytogenetic Status in Multiple Myeloma Based on Magnetic Resonance Imaging: Utility of Radiomics and Comparison of Machine Learning Methods.
    Liu J; Zeng P; Guo W; Wang C; Geng Y; Lang N; Yuan H
    J Magn Reson Imaging; 2021 Oct; 54(4):1303-1311. PubMed ID: 33979466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of Prostate Cancer.
    Ma S; Xie H; Wang H; Han C; Yang J; Lin Z; Li Y; He Q; Wang R; Cui Y; Zhang X; Wang X
    J Magn Reson Imaging; 2019 Dec; 50(6):1914-1925. PubMed ID: 31062459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative MRI-Based Radiomic Machine-Learning Nomogram May Accurately Distinguish Between Benign and Malignant Soft-Tissue Lesions: A Two-Center Study.
    Wang H; Zhang J; Bao S; Liu J; Hou F; Huang Y; Chen H; Duan S; Hao D; Liu J
    J Magn Reson Imaging; 2020 Sep; 52(3):873-882. PubMed ID: 32112598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Triple-Classification Radiomics Model for the Differentiation of Primary Chordoma, Giant Cell Tumor, and Metastatic Tumor of Sacrum Based on T2-Weighted and Contrast-Enhanced T1-Weighted MRI.
    Yin P; Mao N; Zhao C; Wu J; Chen L; Hong N
    J Magn Reson Imaging; 2019 Mar; 49(3):752-759. PubMed ID: 30430686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravoxel Incoherent Motion Imaging in Differentiation Borderline From Malignant Ovarian Epithelial Tumors: Correlation With Histological Cell Proliferation and Vessel Characteristics.
    Song XL; Wang L; Ren H; Wei R; Ren JL; Niu J
    J Magn Reson Imaging; 2020 Mar; 51(3):928-935. PubMed ID: 31373117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography.
    Bickelhaupt S; Paech D; Kickingereder P; Steudle F; Lederer W; Daniel H; Götz M; Gählert N; Tichy D; Wiesenfarth M; Laun FB; Maier-Hein KH; Schlemmer HP; Bonekamp D
    J Magn Reson Imaging; 2017 Aug; 46(2):604-616. PubMed ID: 28152264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive Prediction of High-Grade Prostate Cancer via Biparametric MRI Radiomics.
    Gong L; Xu M; Fang M; Zou J; Yang S; Yu X; Xu D; Zhou L; Li H; He B; Wang Y; Fang X; Dong D; Tian J
    J Magn Reson Imaging; 2020 Oct; 52(4):1102-1109. PubMed ID: 32212356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
    Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
    J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of proton MR spectroscopy in the differentiation of borderline from malignant epithelial ovarian tumors: A preliminary study.
    Ma FH; Li YA; Liu J; Li HM; Zhang GF; Qiang JW
    J Magn Reson Imaging; 2019 Jun; 49(6):1684-1693. PubMed ID: 30353967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.